Form 8-K - Current report:
SEC Accession No. 0001703057-26-000031
Filing Date
2026-06-05
Accepted
2026-06-05 12:03:46
Documents
14
Period of Report
2026-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20260601.htm   iXBRL 8-K 27961
2 EX-99.1 abcellera-appointsxdrxxv.htm EX-99.1 3761
6 abcellera-appointsxdrxxv001.jpg GRAPHIC 136671
7 abcellera-appointsxdrxxv002.jpg GRAPHIC 85973
  Complete submission text file 0001703057-26-000031.txt   451142

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20260601.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20260601_lab.xml EX-101.LAB 20678
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20260601_pre.xml EX-101.PRE 11962
18 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20260601_htm.xml XML 2796
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 261067701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)